# The Medical Center of Aurora
**Type:** Institutions
**Canonical URL:** https://scholariq.org/institutions/the-medical-center-of-aurora/
## Facts
| Field | Value |
| --- | --- |
| Avg h-index | 84.2 |
| Citations | 71,261 |
| City | Aurora |
| Country | US |
| Description | The Medical Center of Aurora is a research organisation in Aurora, US. OpenAlex records 2,280 works and 71,261 citations for it. 886 researchers list it as their most recent affiliation. |
| Homepage | https://auroramed.com/ |
| OpenAlex ID | https://openalex.org/I2802654978 |
| Region | Colorado |
| Researchers | 886 |
| ROR ID | https://ror.org/04qw37741 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7750861 |
| Works | 2,280 |
## University papers
Showing 12 of 56.
- [Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/dapagliflozin-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes](https://scholariq.org/papers/glucose-control-and-vascular-complications-in-veterans-with-type-2-diabetes/)
- [Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses](https://scholariq.org/papers/core-signaling-pathways-in-human-pancreatic-cancers-revealed-by-global-genomic/)
- [Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range](https://scholariq.org/papers/clinical-targets-for-continuous-glucose-monitoring-data-interpretation/)
- [SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials](https://scholariq.org/papers/sglt2-inhibitors-for-primary-and-secondary-prevention-of-cardiovascular-and/)
- [Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children](https://scholariq.org/papers/efficacy-of-larotrectinib-in-i-trk-i-fusion-positive-cancers-in-adults-and/)
- [International Consensus on Use of Continuous Glucose Monitoring](https://scholariq.org/papers/international-consensus-on-use-of-continuous-glucose-monitoring/)
- [Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer](https://scholariq.org/papers/crizotinib-in-i-ros1-i-rearranged-non-small-cell-lung-cancer/)
- [Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction](https://scholariq.org/papers/long-term-use-of-ticagrelor-in-patients-with-prior-myocardial-infarction/)
- [Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials](https://scholariq.org/papers/entrectinib-in-patients-with-advanced-or-metastatic-ntrk-fusion-positive-solid/)
- [The Department of Veterans Affairs' NSQIP](https://scholariq.org/papers/the-department-of-veterans-affairs-nsqip/)
- [Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications](https://scholariq.org/papers/determinants-of-long-term-survival-after-major-surgery-and-the-adverse-effect-of/)
## University researchers
- [William G. Henderson](https://scholariq.org/researchers/william-g-henderson/)
## University top topics
Showing 8 of 25.
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.